Ibaraki, Japan

Ryoko Sata



Average Co-Inventor Count = 9.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2017

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ryoko Sata: Innovator in Antibacterial and Angiogenesis-Inducing Polypeptides

Introduction

Ryoko Sata is a prominent inventor based in Ibaraki, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of polypeptides with antibacterial and angiogenesis-inducing activities. Her innovative work has led to the filing of multiple patents, showcasing her expertise and dedication to advancing medical science.

Latest Patents

Ryoko Sata holds 3 patents that focus on novel polypeptides. Her latest patents include a polypeptide that exhibits both antibacterial activity and angiogenesis-inducing properties. This polypeptide is designed for use in wound healing, providing an effective treatment for various skin conditions such as burns, ulcers, and infections. The amino acid sequences of these polypeptides are detailed in SEQ ID NOs:1 to 6, 8, and 10. These innovations are crucial for improving patient outcomes in medical treatments.

Career Highlights

Throughout her career, Ryoko has worked with notable companies such as Funpep Inc. and Anges Mg, Inc. Her experience in these organizations has allowed her to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Ryoko has collaborated with esteemed colleagues, including Takefumi Gemba and Hideki Tomioka. These partnerships have further enhanced her research and development efforts in the biotechnology sector.

Conclusion

Ryoko Sata's contributions to the field of biotechnology through her innovative polypeptides have the potential to revolutionize wound healing and infection treatment. Her work exemplifies the impact of dedicated inventors in advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…